Molecular Partners Ag (MOLN) Return on Equity: 2022-2025
Historic Return on Equity for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to -594.68%.
- Molecular Partners Ag's Return on Equity fell 38486.00% to -594.68% in Q3 2025 from the same period last year, while for Sep 2025 it was -594.68%, marking a year-over-year decrease of 38486.00%. This contributed to the annual value of -306.35% for FY2024, which is 2641.00% down from last year.
- According to the latest figures from Q3 2025, Molecular Partners Ag's Return on Equity is -594.68%, which was down 5.76% from -562.29% recorded in Q2 2025.
- Molecular Partners Ag's 5-year Return on Equity high stood at 455.30% for Q1 2023, and its period low was -594.68% during Q3 2025.
- For the 3-year period, Molecular Partners Ag's Return on Equity averaged around -179.25%, with its median value being -372.49% (2023).
- In the last 5 years, Molecular Partners Ag's Return on Equity surged by 59,497bps in 2023 and then crashed by 85,706bps in 2024.
- Quarterly analysis of 4 years shows Molecular Partners Ag's Return on Equity stood at 434.32% in 2022, then plummeted by 80,682bps to -372.49% in 2023, then crashed by 6,405bps to -436.54% in 2024, then plummeted by 38,486bps to -594.68% in 2025.
- Its Return on Equity was -594.68% in Q3 2025, compared to -562.29% in Q2 2025 and -463.78% in Q1 2025.